Genetic testing has already been influencing clinical decision-making. A number of single gene tests are available to evaluate breast cancer risk or determine how long a patient with deep vein thrombosis will need to stay on a blood thinner. Soon, clinicians will be incorporating information from significant portions, if not all, of a patient’s entire genome into many aspects of clinical decision-making. A recent symposium on precision medicine at Mayo Clinic (Nov. 2017) suggested a clinical goal of having genomic information preemptively available in the EHR so that it could be seamlessly incorporated into clinical workflow without having to wait for genomic results.

Source: Click here

Share this article

Facebook Comments